Eli Lilly pays record $1.4bn for promoting off-label use of olanzapine
26 januari 2009
The drug giant Eli Lilly has agreed to pay $1.4bn (£1bn; 1.1bn) in settlement for the marketing of its antipsychotic drug olanzapine (Zyprexa) for off-label uses. It is the largest individual corporate fine in history.
Bron: BMJ (registratie verplicht)
| < Vorige | Volgende > |
|---|
